1 / 53

Congenital and acquire Immunodeficiency

Congenital and acquire Immunodeficiency. Wei Chen, Associate professor Institute of Immunology E-mail:chenwei566@zju.edu.cn http://mypage.zju.edu.cn/566 8888. Objectives.

Download Presentation

Congenital and acquire Immunodeficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Congenital and acquire Immunodeficiency Wei Chen, Associate professor Institute of Immunology E-mail:chenwei566@zju.edu.cn http://mypage.zju.edu.cn/566 8888

  2. Objectives • 􀁺 To understand the concept of immunodeficiency. • To know the main types of primary immunodeficiency diseases. • 􀁺 Be able to describe characteristics and consequence of HIV infection.

  3. Content • Introduction • Primary immunodeficiency diseases • Secondary immunodeficiency diseases

  4. Immunodeficiency • Defects in the development and functions of the immune system. • Result in increased susceptibility to infections and in an increased incidence of certain cancers. • Disorders caused by defective immunity are called immunodeficiency diseases.

  5. General feature of immunodeficiency diseases • The principal consequence of immunodeficiency is an increased susceptibility to infection. • Patients with immunodeficiencies are also susceptible to certain types of cancer. • Paradoxically, certain immunodeficiencies are associated with an increased incidence of autoimmunity. • Immunodeficiency may result from defects in lymphocyte development or activation or from defects in the effector mechanisms of innate and adaptive immunity.

  6. Classification • Primary or congenital immunodeficiencies • Present at birth • Result from genetic abnormalities in one or more components of the immune system • Secondary or acquired immunodeficiencies • Later in life • Result from infections, malnutrition, or treatments that cause loss or inadequate function of various components of the immune system • Most common is acquired immunodeficiency syndrome, or AIDS

  7. Content • Introduction • Primary immunodeficiency diseases • Secondary immunodeficiency diseases

  8. Primary immunodeficiency diseases • Severe Combined Immunodeficiencies (SCID) • Antibody Deficiencies: Defects in B Cell Development and Activation • Defects in T Lymphocyte Activation and Function • Defects in Innate Immunity • Multisystem Disorders with immunodeficiency

  9. Features of immunodeficiency diseases

  10. congenital immunodeficiencies caused by defects in lymphocyte maturation

  11. Severe Combined Immunodeficiency Syndromes (SCID) • Congenital immunodeficiencies that affect both humoral and cell-mediated immunity are called combined immunodeficiencies. • characterized by deficiencies of both B and T cells or only of T cells; in the latter cases, the defect in humoral immunity is due to the absence of T cell help. • Children with SCID usually have infections during the first year of life.

  12. Severe Combined Immunodeficiency Syndromes (SCID) • Athymic - DiGeorge Syndrome • X-linked SCID (c deficiency) • Adenosine deaminase deficiency (腺苷脱氨酶) • Jak3 kinase deficiency • Purine nucleoside phosphorylase deficiency • Bare lymphocyte syndrome • RAG1 and RAG2 deficiency

  13. Precursor T cell differentiation defect • Athymic - DiGeorge Syndrome • Sporadic microdeletion of 22q, TBX1 gene (T-box1) • Lack of T helper (Th) cells , Cytotoxic T cells (CTL) and T regulatory (Treg) cells • B cells are present but T-dependent B cell responses are defective • Anti-viral and anti-fungal immunity impaired • Developmental defect in the 3rd and 4th pharyngeal pouch • Results in facial defect and congenital heart disease

  14. DiGeorge syndrome

  15. X-Linked SCID: Common Cytokine Receptor Gamma Chain (gc) Deficiency • Most common form of SCID (40%) • Responsible gene: γc– the common subunit of receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 • Very low T cells and NK cells with low to normal numbers of B cells

  16. Nude Athymic mouse • FOXN1 gene knock-out (autosomal recessive) • Hairless • Should be maintained in pathogen-free environment • T helper cell defect • Results in impaired cytotoxic T cell activity and Th-dependent B cell responses due to Th cell defect • Accept xenografts

  17. Antibody Deficiencies: Defects in B Cell Development and Activation • Bruton’s (X-linked) Agammaglobulinemia • Common Variable Immunodeficiency (CVID) • Autosomal Recessive Hyper-IgM Syndrome • B Cell Receptor Deficiencies • Selective IgA Deficiency • IgG Subclass Deficiency

  18. XLA - BTK defect • Defect in B cell maturation • Genetic disorder - gene on X-chromosome • codes for Bruton’s tyrosine kinase - BTK essential for B cell development

  19. Essential role of BTK

  20. Bruton’s X-linked Agammaglobulinemia • The absence of B cells in blood and IgG • x-linked recessive inheritance, males • Child clinically well for first 6 months of life • Recurrent upper/lower respiratory tract infections with encapsulated bacteria • Sepsis (败血症), meningitis (脑膜炎), skin infections • Paucity of lymphoid tissue (tonsils, adenoids) • Treatment: inject pooled gamma globulin preparations

  21. Common Variable Immunodeficiency • Panhypogammaglobulinemia (全丙种球蛋白过少血症), usually with lymphadenopathy and splenomegaly • Absence of clear abnormalities in T and B cell subsets • Chronic/recurrent respiratory infections, diarrhea(腹泻) • Tendency to develop autoimmunity and lymphoid malignancies • Linkage to HLA Class III Region in 2/3 of patients • One gene identified: ICOS (B7h) (activation antigen on T cells)

  22. Defects in Innate Immunity • Phagocyte Deficiencies: • Chronic granulomatous disease (CGD) • Leukocyte adhesion deficiency (LAD I) • Complement Deficiency • Defects in NK cells and other leukocytes: the Chédiak-Higashi syndrome • Inherited defects in TLR Pathways, NF-κB signaling and type I Interferons • IL-12/IFN pathway deficiencies

  23. Congenital immunodeficiencies caused by defects in innate immunity

  24. Chronic Granulomatous Disease • Inability of phagocytes to generate hydrogen peroxide due to mutations in one of four proteins comprising the NADPH oxidase • Severe tissue infections with catalase positive organisms, esp. Staph aureus, Serratia marcescens, mycobacteria, and fungi such as Aspergillus

  25. Chronic granulomatous disease • Note cervical nodal abscess(头颈淋巴结脓肿) • Gingivitis and periodontitis (牙龈炎和牙周炎) • Abscess indenting the oesophagus(食道脓肿)

  26. CGD patient with skin infections due to Serratia marcescens

  27. Content • Introduction • Primary immunodeficiency diseases • Secondary immunodeficiency diseases

  28. Secondary or acquired immunodeficiency diseases

  29. Human Immunodeficiency Virus • Discovered in 1983 by Luc Montagnier and Robert Gallo • Retrovirus (RNA virus) • HIV-1 (common) and HIV-2 (Africa) • Patients with low CD4+ T cells • Virus prevalent in homosexual, promiscuous heterosexual, i.v. drug users, transfusion, infants born to infected mothers • Opportunistic infections with Pnuemocystis carinii (卡氏肺囊虫), Candida albicans, Mycobacterium avium, etc. • Patients with HIV have high incidence of cancers such as Kaposi sarcoma

  30. Kaposi Sarcoma

  31. Incidence of HIV CDC 2008

  32. HIV - The Virus • A retrovirus • Genetic material is RNA • Transcribed into DNA by RT (reverse transcriptase) • Copy (provirus) inserted into the host genome • When it is expressed to form new virions, the cell lyses • Alternately, it may remain latent in the cell for an extended period of time

  33. The structure of human HIV-1

  34. Genes of human HIV-1

  35. The life cycle of HIV-1 • Infection of cells: gp120 binds to CD4 and CXCR4 on T cells or CCR5 on DC and M. • Production of viral DNA and its integration into the host genome. • Expression of viral genes: production of viral RNAs and then proteins to form a core structure. • Production of viral particles: the core structure migrates to the cell membrane, acquires a lipid envelope from the host, and the viral particle is shed.

  36. The life cycle of HIV-1

  37. Pathogenesis of AIDS • HIV establishes a latent infection in immune cells and may be reactivated to produce infectious virus. This viral production leads to death of infected cells and uninfected lymphocytes, subsequent immunodeficiencies and clinical AIDS. • The depletion of CD4+ T cells after HIV infection is due to a cytopathic effect of the virus, resulting from production of viral particles, as well as death of uninfected cells.

  38. Course of AIDS Dissemination of virus; Seeding of lymphoid organs Anti-HIV Ab/CTL ACUTE CHRONIC AIDS PHASE PHASE AIDS (<200cells/mm3)

  39. The pathogenesis of AIDS

  40. The earliest innate and adaptive immune responses detected after HIV transmission Nat Rev Immunol. 2010,10:11

  41. Animal Models • Primate Model: • HIV grows in chimpanzees but do not develop AIDS • Simian immunodeficiency virus (SIVagm in African green monkey – no disease; SIVmac in Macaques – AIDS like); • Mouse Model: • Grows in Severe Combined Immunodeficiency (SCID) mice reconstituted with human lymphocytes

  42. US Death Rates 25-44 years old

  43. Therapy and vaccination strategies • Several places in virus life-cycle that can be blocked • Attachment/entry • Reverse transcription • Integration • Proteolysis

  44. Reverse Transcription • AZT (zidovudine) • Nucleoside analog - is incorporated into growing chain and causes termination • Side effects • Resistant mutants develop • Nevirapine • Inhibits action of RT

  45. Protease Inhibitors • Blocks action of protease • Huge breakthrough! • Responsible for rapid drop in number of deaths in US

More Related